Latest news Topicort

Sun Pharma: outlook remains positive ... to 70 bps week weak, despite the competition. Also new in October Taros drug application starts in the derm...


Sun Pharma: outlook remains positive
… to 70 bps week weak, despite the competition. Also new in October Taros drug application starts in the dermatology segment; Topicort spray and Calcitreine ointment, further shares have to win in their respective segments adds Mahida.
more Read on

Leave a Reply